Insulet Corporation (PODD)
Last Price$272.70.1%
Market Cap$19.4B
PODD Rating
PODD Quality rating performance
PODD Intrinsic Value
Key Highlights:
As of Mar 03, 2025 PODD Relative Value is $136.4, which is overvalued by 50.0%, compared to current share price of $272.7.
As of Mar 03, 2025 PODD DCF Value is N/A, which is undervalued by N/A, compared to current share price of $272.7.
PODD Share Price History
1W (3.8%)
1M (2.2%)
6M 31.9%
YTD 30.4%
1Y 62.5%
3Y 2.7%
5Y 56.5%
10Y 769.2%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
PODD Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$19.4B
$18.5B
$1,900.3M
$303.0M
Shares Outstanding
71M
Employees
N/A
Growth (CAGR)
20.8%
43.9%
101.97%
21.2%
8.42%
Profitability
76.4%
16.3%
22.0%
22.6%
15.9%
72.4%
Intrinsic Value
$134.5 (50.7% overvalued)
N/A
$134.5
25.1%
Return on Capital
Financial Health
($869.6M)
(2.9x)
8.7x
Dividends
Earnings
May 07, 2025
MISS by (39.4%)
BEAT by 15.6%
(13.5%)
8 Beat & 2 Miss
PODD Stock Financials
PODD Income Statement Metrics
Annual
Quarterly
LTM
PODD Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$145.7M +22.2% YoY
Capital Expenditure (CAPEX)
($75.6M) -30.6% YoY
Free Cash Flow (FCF)
$36.5M N/A YoY
PODD Income Statement Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
$1,697.1M 30.0% YoY
Cost of revenue
$537.2M 7.5% YoY
Pre-tax income
$214.6M 2,089.8% YoY
12.6% margin
PODD Balance Sheet Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$2,588.2M
Current assets ($1,582.9M, 61.2% of total)
$704.2M (27.2%)
$359.7M (13.9%)
Other current assets
$519.0M (20.1%)
Non-current assets ($1,005.3M, 38.8% of total)
$26.6M (1.0%)
$692.8M (26.8%)
$98.7M (3.8%)
Other non-current assets
$187.2M (7.2%)
Financial position
$711.6M
Cash & Short-term
Investments
Total Debt
PODD Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
PODD Earnings Surprises
Crunching data... Almost there!
PODD Dividends
PODD Dividend Yield
Crunching data... Almost there!
PODD Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with PODD
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$19.4B | 7.9 | $134.5 50.7% overvalued | 62.5% | $1,900.3M | $303.0M | 12.0% | 15.9% | 76.4% | 29.7% | 6.9% | |
$242.4B | 7.0 | $174.5 24.5% undervalued | 19.2% | $42.0B | $6,351.0M | 4.6% | 15.1% | 55.6% | 25.3% | 31.4% | |
$154.5B | 6.7 | $34.2 67.4% overvalued | 55.5% | $16.7B | $2,438.0M | 17.6% | 14.6% | 67.0% | 8.0% | 50.7% | |
$150.5B | 6.6 | $305.1 22.7% overvalued | 12.0% | $22.6B | $3,487.0M | 10.2% | 15.4% | 62.8% | 14.6% | 28.4% | |
$120.9B | 6.2 | $114.6 21.5% undervalued | 14.7% | $33.2B | $5,467.0M | 2.7% | 16.5% | 52.7% | 7.4% | 53.6% | |
$43.4B | 6.1 | $54.1 24.2% overvalued | (18.0%) | $5,872.6M | $502.2M | 0.9% | 8.6% | 77.8% | 25.8% | 7.4% | |
$34.9B | 7.0 | $43.1 49.8% overvalued | (29.7%) | $4,033.0M | $453.9M | 11.3% | 11.3% | 60.4% | 21.7% | 120.3% | |
$24.7B | 5.3 | $65.0 146.8% undervalued | 34.0% | €18.0B | €274.0M | (0.8%) | 1.5% | 43.1% | (4.2%) | 63.4% | |
$21.9B | 6.2 | $199.6 10.4% overvalued | (3.8%) | $5,398.4M | $751.4M | (0.2%) | 13.9% | 44.7% | 8.2% | 1.9% | |
$21.6B | 5.9 | $181.2 72.0% undervalued | (15.3%) | $5,655.4M | $1,132.4M | (23.5%) | 20.0% | 64.3% | 4.5% | 43.0% | |
$13.6B | 6.0 | $190.0 8.5% undervalued | (43.2%) | $3,999.0M | $622.7M | 3.5% | 15.6% | 70.3% | 14.2% | 2.3% |
FAQ
What is Insulet Corporation (PODD) stock rating?
As of today, Insulet Corporation has a stock rating of 8 (out of 10), which is considered Great.
is Insulet Corporation (PODD) a good stock to buy?
As of today, Insulet Corporation has a Great stock rating, which is 50.7% overvalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 0.5%.